secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001193125-24-276426
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA to acquire Kineta in stock/cash merger; $35M concurrent financing required
--------------------------------------------------------------------------------

- Consideration per Kineta share: initial stock based on $15M pool, delayed stock based on $5M, plus cash and contingent asset payment rights.
- Closing requires TuHURA to raise at least $35M net proceeds from a concurrent private investment.
- TuHURA will loan Kineta up to $900k at 5% interest to fund R&D expenses, secured by program assets.
- Key conditions: stockholder approvals (Kineta merger vote; TuHURA authorized share increase to 200M), listing, and no law/order preventing deal.
- Termination fee of $1M payable by Kineta if it accepts a superior proposal; $1M by TuHURA if it fails to close the concurrent investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312524276426/0001193125-24-276426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312524276426/d881353d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-276426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer